Together with in vitro experiments, these results proved that HMGB1 knockdown sensitized ESCC cells lines to IR and that HMGB1 inhibitor might be developed as drug to increase radiotherapy effect in ESCC patients. This evidence concerns the gene HMGB1 and esophageal squamous cell carcinoma.